Overall survival | ||||||
---|---|---|---|---|---|---|
Number | Median (months) | |||||
A | B | A | B | P value | ||
All patients | 58 | 36 | 20.2 | 11.9 | 0.001 | |
Age ≦69 | 38 | 20 | 19.7 | 12.9 | 0.061 | NS |
>70 | 20 | 16 | 20.4 | 8.6 | 0.001 | |
Sex: male | 36 | 20 | 20.4 | 6.3 | 0.001 | |
Sex: female | 22 | 16 | 19.8 | 12.6 | 0.094 | NS |
T1–2 | 11 | 9 | 36.6 | 20.5 | 0.086 | NS |
T3–4 | 47 | 27 | 15.6 | 9.4 | 0.000 | |
N0 | 27 | 15 | 21.3 | 13.0 | 0.007 | |
N1 | 31 | 21 | 13.6 | 7.0 | 0.017 | |
R0 | 43 | 28 | 20.7 | 12.5 | 0.001 | |
R1 | 15 | 8 | 13.4 | 5.5 | 0.034 | |
Stage 0–IIA | 29 | 13 | 23.7 | 15.4 | 0.008 | |
Stage IIB–IV | 29 | 23 | 13.4 | 7.0 | 0.043 |